Company: OFIX
Filing Date: 2025-03-12
Form Type: 8-K
Source: 0000950170-25-037630
Chunk: 0

Company: Orthofix Medical Inc.
Filing Date: 2025-03-12
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointment of Principal Officers.

On March 11, 2025, the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”), consistent with a recommendation made by the Board’s Nominating, Governance and Sustainability Committee, appointed Vickie Capps as a director. The Board has determined that Ms. Capps is an independent director under the listing rules of the Nasdaq Stock Market. There are no transactions involving Ms. Capps and the Company requiring disclosure under Item 404(a) of Regulation S-K. Immediately prior to Ms. Capps’s appointment, the Board resolved pursuant to the Company’s bylaws to increase its size from nine to ten directors, effective immediately. The Board expects to determine the committees of the Board on which Ms. Capps will serve at a future date.

Ms. Capps will participate in the Company’s compensation program for its non-employee directors. Also, the Company intends to enter into its standard director indemnification agreement with Ms. Capps.

Item 7.01 Regulation FD Disclosure.